AHS provides wound healing systems based on KCI’s proprietary negative pressure technology platform including VAC Therapy.

As a new president, Woody will be responsible for leading AHS’s research and development, manufacturing, commercialization and clinical and customer support in the Africa, Asia, Americas, Europe and Middle East.

Previously he served at Covidien as a president for its Vascular Therapies and there he was responsible for the $2.6bn acquisition and integration of ev3.

He also served at Smith & Nephew Advanced Wound Management as president and also held other positions at Acuson, Alliance Imaging and GE Medical Systems.

KCI president & CEO Cathy Burzik said Woody’s understanding of the wound therapy segment, his familiarity with its customers and care settings will help take their successful negative pressure therapy franchise and make it even stronger.